Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!).

Sophie Guilmin-CréponJean-Claude CarelJulien SchroedtVéronique SulmontAnne-Sophie SalmonClaire Le TallecRégis CoutantFabienne Dalla-ValeChantal StuckensHélène Bony-TrifunovicHélène CrosnierFrançois KurtzFlorentia KaguelidouAnaïs Le JeannicIsabelle Durand-ZaleskiNathalie CouqueCorinne AlbertiNadia Tubiana-Rufi

Published in: Pediatric diabetes (2019)

None of the three long-term RT-CGM strategies evaluated in pediatric type 1 diabetes was superior to the others in terms of HbA1c levels. CGM-use for 3 months decreased rates of severe hypoglycemia. Our results confirm the feasibility of long-term RT-CGM-use and the need to improve educational support for patients and caregivers.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
glycemic control
prognostic factors
palliative care
early onset
insulin resistance
metabolic syndrome